An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.
about
Biodegradation and cytotoxicity of ciprofloxacin-loaded hydroxyapatite-polycaprolactone nanocomposite film for sustainable bone implants.Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitisVancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.
P2860
An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An in vitro study of composite ...... al treatment of osteomyelitis.
@en
An in vitro study of composite ...... al treatment of osteomyelitis.
@nl
type
label
An in vitro study of composite ...... al treatment of osteomyelitis.
@en
An in vitro study of composite ...... al treatment of osteomyelitis.
@nl
prefLabel
An in vitro study of composite ...... al treatment of osteomyelitis.
@en
An in vitro study of composite ...... al treatment of osteomyelitis.
@nl
P2093
P2860
P356
P1433
P1476
An in vitro study of composite ...... al treatment of osteomyelitis.
@en
P2093
Alexander Efimov
Jaana Rich
Jukka Seppälä
Minna Kellomäki
Minna Veiranto
Niina Ahola
Noora Männistö
P2860
P356
10.4161/BIOM.23162
P50
P577
2013-01-01T00:00:00Z